Literature DB >> 7859586

Effects of acid suppression on microbial flora of upper gut.

N D Yeomans1, R W Brimblecombe, J Elder, R V Heatley, J J Misiewicz, T C Northfield, A Pottage.   

Abstract

Decreased acid secretion, due to therapy or disease, predisposes to increased bacterial counts in gastric juice. As bacterial numbers increase, the number of nitrate-reducing strains and the concentration of luminal nitrite usually also increase. However, there is controversy (mainly because of assay problems) about whether decreased acid increases generation of N-nitroso compounds: these may be produced by acid or by bacterial catalysis, and the relative contributions of each are still uncertain. Other potentially important factors include ascorbate secretion (can prevent nitrite conversion to nitroso compounds) and the particular spectrum of nitroso compounds produced. Nitrosation of several histamine H2-receptor antagonists has been demonstrated experimentally, but under conditions that are very unlikely to be encountered clinically. Some acid suppressant therapies have been claimed to aid eradication of Helicobacter pylori, but more work is needed to evaluate this. If ulcer treatment regimens do not also address eradication of H. pylori (when present), gastritis will progress, and the recently documented association between H. pylori and gastric carcinoma needs to be considered. Enteric flora probably also increase if acid secretion is markedly reduced: this does not appear to have nutritional consequences but probably reduces the resistance to occasional infections, of which cholera is the best documented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859586     DOI: 10.1007/bf02214873

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  123 in total

1.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

2.  Small intestine bacterial overgrowth.

Authors:  C E King; P P Toskes
Journal:  Gastroenterology       Date:  1979-05       Impact factor: 22.682

3.  Severe salmonella gastroenteritis associated with hypochlorhydria.

Authors:  J A Gray; A M Trueman
Journal:  Scott Med J       Date:  1971-05       Impact factor: 0.729

4.  [Bacteriology of the stomach after operation (author's transl)].

Authors:  V Schumpelick; H H Schassan
Journal:  Langenbecks Arch Chir       Date:  1980

5.  The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer.

Authors:  K Jaskiewicz; H D Louwrens; C W Woodroof; M J van Wyk; S K Price
Journal:  S Afr Med J       Date:  1989-05-06

6.  Absence of DNA damage in liver of rats given high doses of cimetidine and sodium nitrite.

Authors:  G Brambilla; M Cavanna; A Maura; A Pino; L Robbiano; P Carlo; F Biassoni; R Ricci
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

7.  Fine structure of the gastric mucous and endocrine cells of the toad, Bufo marinus.

Authors:  A S Giraud; N D Yeomans
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

8.  Gastric adenocarcinoma and Helicobacter pylori infection.

Authors:  N J Talley; A R Zinsmeister; A Weaver; E P DiMagno; H A Carpenter; G I Perez-Perez; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1991-12-04       Impact factor: 13.506

9.  Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.

Authors:  A Berstad; B Alexander; R Weberg; A Serck-Hanssen; S Holland; B I Hirschowitz
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach.

Authors:  G M Sobala; B Pignatelli; C J Schorah; H Bartsch; M Sanderson; M F Dixon; S Shires; R F King; A T Axon
Journal:  Carcinogenesis       Date:  1991-02       Impact factor: 4.944

View more
  12 in total

1.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.

Authors:  K H Gan; W P Geus; C B Lamers; H G Heijerman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

Review 3.  Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.

Authors:  F Dhalla; S P da Silva; M Lucas; S Travis; H Chapel
Journal:  Clin Exp Immunol       Date:  2011-04-06       Impact factor: 4.330

Review 4.  Participation of microbiota in the development of gastric cancer.

Authors:  Li-Li Wang; Xin-Juan Yu; Shu-Hui Zhan; Sheng-Jiao Jia; Zi-Bin Tian; Quan-Jiang Dong
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 5.  Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.

Authors:  Rami B Ibrahim; Muneer H Abidi; Simon M Cronin; Lawrence G Lum; Zaid Al-Kadhimi; Voravit Ratanatharathorn; Joseph P Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2009-02-10       Impact factor: 5.742

Review 6.  The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis.

Authors:  Alexander Sheh; James G Fox
Journal:  Gut Microbes       Date:  2013-08-19

7.  Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia.

Authors:  W Ye; O Nyrén
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 8.  Long-term proton pump inhibitor use and gastrointestinal cancer.

Authors:  David Y Graham; Robert M Genta
Journal:  Curr Gastroenterol Rep       Date:  2008-12

9.  Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Authors:  M C Bradley; L J Murray; M M Cantwell; C M Hughes
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

Review 10.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.